Exhibit 99.7
Form 51-102F3
Material Change Report
Item 1
Name and Address of Company
VANC PHARMACEUTICALS INC.
1128-789 West Pender Street
Vancouver, BC
V6C 1H2 (the “Company”)
Item 2
Date of Material Change
May 17, 2016
Item 3
News Release
The news release was disseminated on May 17, 2016 by way of the facilities of Stockwatch and Market News. Copies were also filed on SEDAR with the British Columbia Securities Commission and the Alberta Securities Commission.
Item 4
Summary of Material Change
The Company announced it changed their auditor.
Item 5
Full Description of Material Change
5.1
Full Description of Material Change
The Company announced the board of directors of the Company has appointed Adam Sung Kim Ltd., Chartered Professional Accountants as the Company’s new auditor, replacing Smythe LLP, Chartered Accountants. The Company has filed a Notice of Change of Auditors in respect of this change under its profile on SEDAR atwww.sedar.com .
5.2
Disclosure for Restructuring Transactions
Not applicable.
Item 6
Reliance on subsection 7.1(2) of National Instrument 51-102
Not applicable.
Item 7
Omitted Information
Not applicable.
Item 8
Executive Officer
Eugene Beukman, Director and Chief Financial Officer
Business Telephone:
604.687-2038
Facsimile:
604.687-3141
Item 9
Date of Report
May 17, 2016